News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Transition Therapeutics Inc. (TTH.TO) Announces the Departure of Its President and Chief Financial Officer


12/12/2011 9:57:46 AM

TORONTO, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition") (TSX:TTH) (Nasdaq:TTHI) today announces that Mr. Elie Farah, the Company's President and Chief Financial Officer, has left the Company to pursue new challenges. During his time at Transition, Mr. Farah played an instrumental role in the Company listing on the NASDAQ, completing several equity financings, managing and executing multiple company acquisitions as well as licensing agreements with large pharmaceutical companies.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES